LIPOSORBER® LDL Apheresis - Treatment Option for Familial Hypercholesterolemia
Liposorber LDL Apheresis is for refractory hypercholesterolemia patients whose LDL-C cannot be controlled by Statins such as homozygotes / heterozygotes Familial Hypercholesterolemia. Acute reduction rate of LDL Cholesterol is 73%-83%
Liposorber, Kaneka, Kaneka Pharma America, familial hypercholesterolemia, LDL-apheresis, LDL apheresis, LDL-cholesterol, LDL cholesterol, cholesterol lowering, LA-15, LA 15, refractoriness to statins, familial hyperlipidemia, hypercholesterolemia, apheres
Is this your site? Certify your site and update informations
